Differential protein expressions in renal cell carcinoma: New biomarker discovery by mass spectrometry

Journal of Proteome Research

Volumn 8, Issue 8, 2009, Pages 3797-3807

  Siu, K W Michael ^a   DeSouza, Leroi V ^a   Scorilas, Andreas ^b   Romaschin, Alexander D ^c,d   Honey, R John ^e   Stewart, Robert ^e   Pace, Kenneth ^e   Youssef, Youssef ^c   Chow, Tsz Fung F ^c   Yousef, George M ^c,d  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF ATHENS   (Greece)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

iTRAQ; Kidney cancer; LC MS MS; Mass spectrometry; Proteomics; Renal cell carcinoma; Tumor markers

Indexed keywords

ONCOPROTEIN; TUMOR MARKER;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UNINDEXED SEQUENCE;

CARCINOMA, RENAL CELL; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; KIDNEY NEOPLASMS; MODELS, GENETIC; NEOPLASM PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 68549106345     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800389e     Document Type: Article

References (64)

1. McLaughlin, J. K.; Lipworth, L.; Tarone, R. E. Epidemiologic aspects of renal cell carcinoma. Semin. Oncol. 2006, 33 (5), 527-533.
2. Weiss, R. H.; Lin, P. Y. Kidney cancer: identification of novel targets for therapy. Kidney Int. 2006, 69 (2), 224-232.
3. Ornstein, D. K.; Tyson, D. R. Proteomics for the identification of new prostate cancer biomarkers. Urol. Oncol. 2006, 24 (3), 231-236.
4. Emmert-Buck, M. R.; Gillespie, J. W.; Paweletz, C. P.; Ornstein, D. K.; Basrur, V.; Appella, E.; Wang, Q. H.; Huang, J.; Hu, N.; Taylor, P.; Petricoin, E. F. III An approach to proteomic analysis of human tumors. Mol. Carcinog. 2000, 27 (3), 158-165.
5. Shi, T.; Dong, F.; Liou, L. S.; Duan, Z. H.; Novick, A. C.; DiDonato, J. A. Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 2004, 40 (1), 47-61.
6. Bradford, T. J.; Tomlins, S. A.; Wang, X.; Chinnaiyan, A. M. Molecular markers of prostate cancer. Urol. Oncol. 2006, 24 (6), 538-551.
7. DeSouza, L.; Diehl, G.; Rodrigues, M. J.; Guo, J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005, 4 (2), 377-386.
8. DeSouza, L. V.; Grigull, J.; Ghanny, S.; Dube, V.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2007, 6 (7), 1170-1182.
9. Yang, E. C.; Guo, J.; Diehl, G.; DeSouza, L.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. J. Proteome Res. 2004, 3 (3), 636-643.
10. Grassl, J.; Morishita, M.; Lewis, P. D.; Leonard, R. C.; Thomas, G. Profiling the breast cancer proteome-the new tool of the future? Clin. Oncol. (R. Coll. Radiol.) 2006, 18 (8), 581-586.
11. Yu, K. H.; Rustgi, A. K.; Blair, I. A. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J. Proteome Res. 2005, 4 (5), 1742-1751.
12. Matta, A.; DeSouza, L. V.; Shukla, N. K.; Gupta, S. D.; Ralhan, R.; Siu, K. W. Prognostic Significance of Head-and-Neck Cancer Biomarkers Previously Discovered and Identified Using iTRAQLabeling and Multidimensional Liquid Chromatography-Tandem Mass Spectrometry. J. Proteome Res. 2008, 7 (5), 2078-2087.
13. Ralhan, R.; DeSouza, L. V.; Matta, A.; Chandra, T. S.; Ghanny, S.; Datta, G. S.; Bahadur, S.; Siu, K. W. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ-labeling and multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2008.
14. Ornstein, D. K.; Tyson, D. R. Proteomics for the identification of new prostate cancer biomarkers. Urol. Oncol. 2006, 24 (3), 231-236.
15. Aebersold, R.; Goodlett, D. R. Mass spectrometry in proteomics. Chem. Rev. 2001, 101 (2), 269-295.
16. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17 (10), 994-999.
17. Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet.Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3 (12), 1154-1169.
18. DeSouza, L.; Diehl, G.; Rodrigues, M. J.; Guo, J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005, 4 (2), 377-386.
19. DeSouza, L. V.; Grigull, J.; Ghanny, S.; Dube, V.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2007, 6 (7), 1170-1182.
20. Yang, E. C.; Guo, J.; Diehl, G.; DeSouza, L.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. J. Proteome Res. 2004, 3 (3), 636-643.
21. Pavlovich, C. P.; Schmidt, L. S. Searching for the hereditary causes of renal-cell carcinoma. Nat. Rev. Cancer 2004, 4 (5), 381-393.
22. Sarto, C.; Marocchi, A.; Sanchez, J. C.; Giannone, D.; Frutiger, S.; Golaz, O.; Wilkins, M. R.; Doro, G.; Cappellano, F.; Hughes, G.; Hochstrasser, D. F.; Mocarelli, P. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997, 18 (3-4), 599-604.
23. Shi, T.; Dong, F.; Liou, L. S.; Duan, Z. H.; Novick, A. C.; DiDonato, J. A. Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 2004, 40 (1), 47-61.
24. Adachi, J.; Kumar, C.; Zhang, Y.; Olsen, J. V.; Mann, M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7 (9), R80.
25. DeSouza, L.; Diehl, G.; Yang, E. C.; Guo, J.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Proteomic analysis of the proliferative and secretory phases of the human endometrium: protein identification and differential protein expression. Proteomics 2005, 5 (1), 270-281.
26. DeSouza, L. V.; Grigull, J.; Ghanny, S.; Dube, V.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2007, 6 (7), 1170-1182.
27. Shilov, I. V.; Seymour, S. L.; Patel, A. A.; Loboda, A.; Tang, W. H.; Keating, S. P.; Hunter, C. L.; Nuwaysir, L. M.; Schaeffer, D. A. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 2007, 6 (9), 1638-1655.
28. Ralhan, R.; DeSouza, L. V.; Matta, A.; Chandra, T. S.; Ghanny, S.; Datta, G. S.; Bahadur, S.; Siu, K. W. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ-labeling and multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 2008.
29. Craven, R. A.; Stanley, A. J.; Hanrahan, S.; Dods, J.; Unwin, R.; Totty, N.; Harnden, P.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006, 6 (9), 2853-2864.
30. Perego, R. A.; Bianchi, C.; Corizzato, M.; Eroini, B.; Torsello, B.; Valsecchi, C.; Di.Fonzo, A.; Cordani, N.; Favini, P.; Ferrero, S.; Pitto, M.; Sarto, C.; Magni, F.; Rocco, F.; Mocarelli, P. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. J. Proteome Res. 2005, 4 (5), 1503-1510.
31. Sarto, C.; Marocchi, A.; Sanchez, J. C.; Giannone, D.; Frutiger, S.; Golaz, O.; Wilkins, M. R.; Doro, G.; Cappellano, F.; Hughes, G.; Hochstrasser, D. F.; Mocarelli, P. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997, 18 (3-4), 599-604.
32. Shi, T.; Dong, F.; Liou, L. S.; Duan, Z. H.; Novick, A. C.; DiDonato, J. A. Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 2004, 40 (1), 47-61.
33. DeSouza, L.; Diehl, G.; Yang, E. C.; Guo, J.; Rodrigues, M. J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Proteomic analysis of the proliferative and secretory phases of the human endometrium: protein identification and differential protein expression. Proteomics 2005, 5 (1), 270-281.
34. Craven, R. A.; Stanley, A. J.; Hanrahan, S.; Dods, J.; Unwin, R.; Totty, N.; Harnden, P.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006, 6 (9), 2853-2864.
35. Perego, R. A.; Bianchi, C.; Corizzato, M.; Eroini, B.; Torsello, B.; Valsecchi, C.; Di Fonzo, A.; Cordani, N.; Favini, P.; Ferrero, S.; Pitto, M.; Sarto, C.; Magni, F.; Rocco, F.; Mocarelli, P. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. J. Proteome Res. 2005, 4 (5), 1503-1510.
36. Sarto, C.; Marocchi, A.; Sanchez, J. C.; Giannone, D.; Frutiger, S.; Golaz, O.; Wilkins, M. R.; Doro, G.; Cappellano, F.; Hughes, G.; Hochstrasser, D. F.; Mocarelli, P. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997, 18 (3-4), 599-604.
37. Shi, T.; Dong, F.; Liou, L. S.; Duan, Z. H.; Novick, A. C.; DiDonato, J. A. Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 2004, 40 (1), 47-61.
38. Izquierdo, M. A.; Scheffer, G. L.; Flens, M. J.; Giaccone, G.; Broxterman, H. J.; Meijer, C. J.; van, d. V.; Scheper, R. J. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am. J. Pathol. 1996, 148 (3), 877-887.
39. Ferguson, R. E.; Jackson, S. M.; Stanley, A. J.; Joyce, A. D.; Harnden, P.; Morrison, E. E.; Patel, P. M.; Phillips, R. M.; Selby, P. J.; Banks, R. E. Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma. Int. J. Cancer 2005, 115 (1), 155-163.
40. Gagne, J. P.; Ethier, C.; Gagne, P.; Mercier, G.; Bonicalzi, M. E.; Mes-Masson, A. M.; Droit, A.; Winstall, E.; Isabelle, M.; Poirier, G. G. Comparative proteome analysis of human epithelial ovarian cancer. Proteome Sci. 2007, 5, 16.
41. Izquierdo, M. A.; Scheffer, G. L.; Flens, M. J.; Giaccone, G.; Broxterman, H. J.; Meijer, C. J.; van, d. V.; Scheper, R. J. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am. J. Pathol. 1996, 148 (3), 877-887.
42. Yao, M.; Tabuchi, H.; Nagashima, Y.; Baba, M.; Nakaigawa, N.; Ishiguro, H.; Hamada, K.; Inayama, Y.; Kishida, T.; Hattori, K.; Yamada-Okabe, H.; Kubota, Y. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J. Pathol. 2005, 205 (3), 377-387.
43. Yao, M.; Huang, Y.; Shioi, K.; Hattori, K.; Murakami, T.; Nakaigawa, N.; Kishida, T.; Nagashima, Y.; Kubota, Y. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin. Cancer Res. 2007, 13 (1), 152-160.
44. Yao, M.; Tabuchi, H.; Nagashima, Y.; Baba, M.; Nakaigawa, N.; Ishiguro, H.; Hamada, K.; Inayama, Y.; Kishida, T.; Hattori, K.; Yamada-Okabe, H.; Kubota, Y. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J. Pathol. 2005, 205 (3), 377-387.
45. Sartini, D.; Santarelli, A.; Rossi, V.; Goteri, G.; Rubini, C.; Ciavarella, D.; Lo, M. L.; Emanuelli, M. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol. Med. 2007, 13 (7-8), 415-421.
46. Williams, A. C.; Ramsden, D. B. Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases. Med. Hypotheses 2005, 65 (2), 353-362.
47. Sartini, D.; Santarelli, A.; Rossi, V.; Goteri, G.; Rubini, C.; Ciavarella, D.; Lo, M. L.; Emanuelli, M. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol. Med. 2007, 13 (7-8), 415-421.
48. Kassem, H. S.; Sangar, V.; Cowan, R.; Clarke, N.; Margison, G. P. A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int. J. Cancer 2002, 101 (5), 454-460.
49. Mizutani, Y.; Wada, H.; Yoshida, O.; Fukushima, M.; Kawauchi, A.; Nakao, M.; Miki, T. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma. Cancer 2003, 98 (4), 730-736.
50. Takayama, T.; Mugiya, S.; Sugiyama, T.; Aoki, T.; Furuse, H.; Liu, H.; Hirano, Y.; Kai, F.; Ushiyama, T.; Ozono, S. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma. Jpn. J. Clin. Oncol. 2006, 36 (9), 564-569.
51. Takayama, T.; Mugiya, S.; Sugiyama, T.; Aoki, T.; Furuse, H.; Liu, H.; Hirano, Y.; Kai, F.; Ushiyama, T.; Ozono, S. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma. Jpn. J. Clin. Oncol. 2006, 36 (9), 564-569.
52. Shi, T.; Dong, F.; Liou, L. S.; Duan, Z. H.; Novick, A. C.; DiDonato, J. A. Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 2004, 40 (1), 47-61.
53. Pinder, S. E.; Balsitis, M.; Ellis, I. O.; Landon, M.; Mayer, R. J.; Lowe, J. The expression of alpha B-Crystallin in epithelial tumours: a useful tumour marker. J. Pathol. 1994, 174 (3), 209-215.
54. Skopeliti, M.; Kratzer, U.; Altenberend, F.; Panayotou, G.; Kalbacher, H.; Stevanovic, S.; Voelter, W.; Tsitsilonis, O. E. Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation. Proteomics 2007, 7 (11), 1814-1824.
55. Letsas, K. P.; Vartholomatos, G.; Tsepi, C.; Tsatsoulis, A.; Frangou-Lazaridis, M. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers. Neoplasma 2007, 54 (1), 57-62.
56. Mori, M.; Barnard, G. F.; Staniunas, R. J.; Jessup, J. M.; Steele, G. D., Jr.; Chen, L. B. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 1993, 8 (10), 2821-2826.
57. Ralhan, R.; DeSouza, L. V.; Matta, A.; Chandra, T. S.; Ghanny, S.; Datta, G. S.; Bahadur, S.; Siu, K. W. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ-labeling and multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell Proteomics 2008.
58. Sasaki, H.; Nonaka, M.; Fujii, Y.; Yamakawa, Y.; Fukai, I.; Kiriyama, M.; Sasaki, M. Expression of the prothymosin-a gene as a prognostic factor in lung cancer. Surg. Today 2001, 31 (10), 936-938.
59. Traub, F.; Jost, M.; Hess, R.; Schorn, K.; Menzel, C.; Budde, P.; Schulz.Knappe, P.; Lamping, N.; Pich, A.; Kreipe, H.; Tammen, H. Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas. Lab. Invest. 2006, 86 (3), 246-253.
60. Tsitsiloni, O. E.; Stiakakis, J.; Koutselinis, A.; Gogas, J.; Markopoulos, C.; Yialouris, P.; Bekris, S.; Panoussopoulos, D.; Kiortsis, V.; Voelter, W. Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (20), 9504-9507.
61. Wu, C. G.; Habib, N. A.; Mitry, R. R.; Reitsma, P. H.; van Deventer, S. J.; Chamuleau, R. A. Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br. J. Cancer 1997, 76 (9), 1199-1204.
62. Yaffe, M. B.; Rittinger, K.; Volinia, S.; Caron, P. R.; Aitken, A.; Leffers, H.; Gamblin, S. J.; Smerdon, S. J.; Cantley, L. C. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997, 91 (7), 961-971.
63. Ostareck-Lederer, A.; Ostareck, D. H.; Hentze, M. W. Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2. Trends Biochem. Sci. 1998, 23 (11), 409-411.
64. Roy, M.; Xu, Q.; Lee, C. Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res. 2005, 33 (16), 5026-5033.